Total Payments
$6,468
2024 Payments
$1,997
Companies
20
Transactions
317
Payment Breakdown by Category
Food & Beverage$6,369 (98.5%)
Education$99.00 (1.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,369 | 316 | 98.5% |
| Education | $99.00 | 1 | 1.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,814 | 136 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $1,028 | 48 | $0 (2024) |
| Janssen Biotech, Inc. | $721.82 | 33 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $360.44 | 20 | $0 (2024) |
| Celgene Corporation | $332.09 | 26 | $0 (2023) |
| Regeneron Healthcare Solutions, Inc. | $215.95 | 9 | $0 (2024) |
| PFIZER INC. | $191.78 | 8 | $0 (2024) |
| INTERCEPT PHARMACEUTICALS, INC. | $187.88 | 10 | $0 (2023) |
| GENZYME CORPORATION | $147.81 | 5 | $0 (2024) |
| Madrigal Pharmaceuticals | $93.36 | 5 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,997 | 89 | ABBVIE INC. ($888.47) |
| 2023 | $2,076 | 106 | ABBVIE INC. ($709.15) |
| 2022 | $1,583 | 86 | ABBVIE INC. ($785.12) |
| 2021 | $811.08 | 36 | AbbVie Inc. ($431.23) |
All Payment Transactions
317 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $24.76 | General |
| Category: Gastroenterology | ||||||
| 12/19/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $25.22 | General |
| Category: IMMUNOLOGY | ||||||
| 12/17/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $19.44 | General |
| Category: INTERNAL MEDICINE | ||||||
| 12/11/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $21.14 | General |
| Category: Immunology | ||||||
| 12/09/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $12.67 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/05/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $14.86 | General |
| Category: Immunology | ||||||
| 12/03/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $26.13 | General |
| Category: IMMUNOLOGY | ||||||
| 11/27/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $17.46 | General |
| Category: Gastroenterology | ||||||
| 11/25/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $19.51 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/21/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: IMMUNOLOGY | ||||||
| 11/20/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $19.61 | General |
| Category: LIVER DISEASE | ||||||
| 11/18/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $12.93 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/14/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $22.42 | General |
| Category: Immunology | ||||||
| 11/11/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $26.07 | General |
| Category: Immunology | ||||||
| 11/07/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $20.33 | General |
| Category: Immunology | ||||||
| 11/07/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $17.63 | General |
| Category: LIVER DISEASE | ||||||
| 11/05/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $20.03 | General |
| Category: IMMUNOLOGY | ||||||
| 10/30/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $17.07 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/28/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $16.17 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/24/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $22.81 | General |
| Category: IMMUNOLOGY | ||||||
| 10/23/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $21.01 | General |
| Category: Gastroenterology | ||||||
| 10/22/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $17.83 | General |
| Category: LIVER DISEASE | ||||||
| 10/10/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $15.63 | General |
| Category: LIVER DISEASE | ||||||
| 10/10/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $12.58 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/08/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $16.98 | General |
| Category: Immunology | ||||||
About Sara Andolina, NP
Sara Andolina, NP is a Family healthcare provider based in Oceanside, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/24/2014. The National Provider Identifier (NPI) number assigned to this provider is 1194142570.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Sara Andolina, NP has received a total of $6,468 in payments from pharmaceutical and medical device companies, with $1,997 received in 2024. These payments were reported across 317 transactions from 20 companies. The most common payment nature is "Food and Beverage" ($6,369).
Ad
Practice Information
- Specialty Family
- Location Oceanside, CA
- Active Since 03/24/2014
- Last Updated 02/25/2021
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1194142570
Products in Payments
- ENTYVIO (Biological) $934.61
- RINVOQ (Biological) $683.86
- SKYRIZI (Biological) $675.20
- LINZESS (Drug) $522.14
- STELARA (Biological) $477.64
- HUMIRA (Biological) $397.91
- DUPIXENT (Biological) $363.76
- ZEPOSIA (Drug) $332.09
- XIFAXAN (Drug) $216.73
- CREON (Drug) $204.84
- MAVYRET (Drug) $196.58
- XELJANZ (Drug) $191.78
- OCALIVA (Drug) $187.88
- TRULANCE (Drug) $143.71
- VIBERZI (Drug) $133.44
- REMICADE (Biological) $126.70
- TREMFYA (Drug) $117.48
- RESMETIROM (Drug) $93.36
- OMVOH (Drug) $86.71
- AVSOLA (Biological) $61.83
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Oceanside
Mrs. Frances Peredo, Fnp, FNP
Family — Payments: $3,063
Family $3,063
Tobiah Clukey, Fnp-C, FNP-C
Family — Payments: $2,835
Family $2,835
Chasidy Vitale, Fnp, FNP
Family — Payments: $1,775
Family $1,775
Mr. David Julien, Fnp, FNP
Family — Payments: $1,124
Family $1,124
Jennifer Egbert, F.n.p, F.N.P
Family — Payments: $1,060
Family $1,060
Judith Brown, Np, NP
Family — Payments: $871.62
Family $871.62